Tuesday, November 15, 2022

Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) can resolve their persistent symptoms

 A subset of 24 patients was treated with one month of dual antiplatelet therapy (DAPT) (Clopidogrel 75mg/Aspirin 75mg) once a day, as well as a direct oral anticoagulant (DOAC) (Apixiban) 5 mg twice a day. A proton pump inhibitor (PPI) pantoprazole 40 mg/day was also prescribed for gastric protection.

https://www.researchsquare.com/article/rs-1205453/v1

Apixaban (Oral Route)

US Brand Name

  1. Eliquis

https://www.mayoclinic.org/drugs-supplements/apixaban-oral-route/description/drg-20060729

No comments: